SABIC launches LNP ELCRIN DC0051RC1 — 75% PCR carbon-fiber PC compound

Key highlights
  • Contains 75% post-consumer recycled (PCR) content.
  • SABIC’s first PCR-based carbon fiber-reinforced compound, formulated with polycarbonate (PC) resin.
  • Achieves UL94 V0 flame retardancy at 0.8 mm and offers high modulus, dimensional stability and low warpage for thin-wall parts.
  • Uses non-chlorinated, non-brominated flame retardant chemistry and is commercially available globally.

Product

SABIC introduced LNP ELCRIN DC0051RC1, a carbon fiber‑reinforced compound formulated with polycarbonate resin that contains 75 percent post-consumer recycled (PCR) content. It is noted as SABIC’s first PCR-based carbon fiber‑reinforced compound and is positioned for consumer electronics housings.

Performance and compliance

The material delivers high modulus, excellent dimensional stability and low warpage suitable for laptop housings and other large, structural thin‑wall components. SABIC reports the compound meets UL94 V0 flame retardancy at 0.8 mm.

Circularity and formulation

SABIC says the formulation was developed to support circularity goals while retaining key mechanical and flame retardant properties. The compound uses a non‑chlorinated, non‑brominated flame retardant chemistry to reduce potential health and environmental impacts.

Availability

LNP ELCRIN DC0051RC1 is commercially available worldwide.

Source: SABIC

chemXplore Weekly

The week’s project milestones and project news from the chemical industry, free every Wednesday.

Free. One email a week. Unsubscribe any time.

Related articles

23 April 2026
POLYVANTIS Debuts PLEXIGLAS in India

Adds PMMA and polycarbonate thermoplastics to the portfolio: high-performance alternatives for roofing, façades and skylights — durable, lightweight, low‑maintenance, UV/fire‑resistant.

6 April 2026
Trinseo: The Node That Ran Out of Time

Lender waivers expiring; missed interest; market cap far below debt. Costly M&A and validated PC/ABS dissolution recycling tech, but cash‑strapped amid energy shocks and no sovereign backer—sale likely.

3 February 2026
SABIC Introduces Biocompatible Materials and Fluoropolymer Alternatives at MD&M West

Showcasing medical-grade thermoplastics, SABIC addresses performance and regulatory challenges, offering solutions for drug delivery, patient testing, and surgical applications.

8 January 2026
SABIC Divests European Petrochemicals and Americas/Europe Engineering Thermoplastics for $950 Million

The divestments aim to optimize the portfolio, enhance cash flow, and focus on high-margin markets, while maintaining strategic access and customer service.

13 October 2025
POLYVANTIS Launches Shanghai Technology Center, Expands Innovation Network

The new center in Shanghai enhances product development, supports high-growth markets, and strengthens customer collaboration in Asia.